These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 19897420)

  • 1. Heteromerization of dopamine D2 receptors with dopamine D1 or D5 receptors generates intracellular calcium signaling by different mechanisms.
    Hasbi A; O'Dowd BF; George SR
    Curr Opin Pharmacol; 2010 Feb; 10(1):93-9. PubMed ID: 19897420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium signaling by dopamine D5 receptor and D5-D2 receptor hetero-oligomers occurs by a mechanism distinct from that for dopamine D1-D2 receptor hetero-oligomers.
    So CH; Verma V; Alijaniaram M; Cheng R; Rashid AJ; O'Dowd BF; George SR
    Mol Pharmacol; 2009 Apr; 75(4):843-54. PubMed ID: 19171671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine D1-D2 receptor Heteromer-mediated calcium release is desensitized by D1 receptor occupancy with or without signal activation: dual functional regulation by G protein-coupled receptor kinase 2.
    Verma V; Hasbi A; O'Dowd BF; George SR
    J Biol Chem; 2010 Nov; 285(45):35092-103. PubMed ID: 20807772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal.
    Lee SP; So CH; Rashid AJ; Varghese G; Cheng R; Lança AJ; O'Dowd BF; George SR
    J Biol Chem; 2004 Aug; 279(34):35671-8. PubMed ID: 15159403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel dopamine receptor signaling unit in brain: heterooligomers of D1 and D2 dopamine receptors.
    George SR; O'Dowd BF
    ScientificWorldJournal; 2007 Nov; 7():58-63. PubMed ID: 17982577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A peptide targeting an interaction interface disrupts the dopamine D1-D2 receptor heteromer to block signaling and function in vitro and in vivo: effective selective antagonism.
    Hasbi A; Perreault ML; Shen MY; Zhang L; To R; Fan T; Nguyen T; Ji X; O'Dowd BF; George SR
    FASEB J; 2014 Nov; 28(11):4806-20. PubMed ID: 25063849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq/11 in the striatum.
    Rashid AJ; So CH; Kong MM; Furtak T; El-Ghundi M; Cheng R; O'Dowd BF; George SR
    Proc Natl Acad Sci U S A; 2007 Jan; 104(2):654-9. PubMed ID: 17194762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium signaling cascade links dopamine D1-D2 receptor heteromer to striatal BDNF production and neuronal growth.
    Hasbi A; Fan T; Alijaniaram M; Nguyen T; Perreault ML; O'Dowd BF; George SR
    Proc Natl Acad Sci U S A; 2009 Dec; 106(50):21377-82. PubMed ID: 19948956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of c-fos expression by the dopamine D1-D2 receptor heteromer.
    Perreault ML; Shen MY; Fan T; George SR
    Neuroscience; 2015 Jan; 285():194-203. PubMed ID: 25446350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization of the dopamine D1 and D2 receptor hetero-oligomer mediated calcium signal by agonist occupancy of either receptor.
    So CH; Verma V; O'Dowd BF; George SR
    Mol Pharmacol; 2007 Aug; 72(2):450-62. PubMed ID: 17519357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of a dopamine receptor complex amplifies the actions of cocaine.
    Perreault ML; Hasbi A; Shen MYF; Fan T; Navarro G; Fletcher PJ; Franco R; Lanciego JL; George SR
    Eur Neuropsychopharmacol; 2016 Sep; 26(9):1366-1377. PubMed ID: 27480020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heterodimeric D1-D2 dopamine receptors: a review].
    Vekshina NL; Anokhin PK; Veretinskaya AG; Shamakina IY
    Biomed Khim; 2017 Jan; 63(1):5-12. PubMed ID: 28251946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine D1-D2 receptor heteromer signaling pathway in the brain: emerging physiological relevance.
    Hasbi A; O'Dowd BF; George SR
    Mol Brain; 2011 Jun; 4():26. PubMed ID: 21663703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D1-D2 dopamine receptor synergy promotes calcium signaling via multiple mechanisms.
    Chun LS; Free RB; Doyle TB; Huang XP; Rankin ML; Sibley DR
    Mol Pharmacol; 2013 Aug; 84(2):190-200. PubMed ID: 23680635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptor subtypes in the human pulmonary arterial tree.
    Ricci A; Mignini F; Tomassoni D; Amenta F
    Auton Autacoid Pharmacol; 2006 Oct; 26(4):361-9. PubMed ID: 16968475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence against dopamine D1/D2 receptor heteromers.
    Frederick AL; Yano H; Trifilieff P; Vishwasrao HD; Biezonski D; Mészáros J; Urizar E; Sibley DR; Kellendonk C; Sonntag KC; Graham DL; Colbran RJ; Stanwood GD; Javitch JA
    Mol Psychiatry; 2015 Nov; 20(11):1373-85. PubMed ID: 25560761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ethanol inhibition of lateral orbitofrontal cortex neuron excitability is mediated via dopamine D1/D5 receptor-induced release of astrocytic glycine.
    Nimitvilai-Roberts S; Gioia D; Zamudio PA; Woodward JJ
    Neuropharmacology; 2021 Jul; 192():108600. PubMed ID: 33965399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine induces a biphasic modulation of hypothalamic ANF neurons: a ligand concentration-dependent effect involving D5 and D2 receptor interaction.
    Lee D; Huang W; Lim AT
    Mol Psychiatry; 2000 Jan; 5(1):39-48. PubMed ID: 10673767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposing effects of phorbol-12-myristate-13-acetate, an activator of protein kinase C, on the signaling of structurally related human dopamine D1 and D5 receptors.
    Jackson A; Sedaghat K; Minerds K; James C; Tiberi M
    J Neurochem; 2005 Dec; 95(5):1387-400. PubMed ID: 16313517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine/serotonin receptor ligands. 10: SAR Studies on azecine-type dopamine receptor ligands by functional screening at human cloned D1, D2L, and D5 receptors with a microplate reader based calcium assay lead to a novel potent D1/D5 selective antagonist.
    Hoefgen B; Decker M; Mohr P; Schramm AM; Rostom SA; El-Subbagh H; Schweikert PM; Rudolf DR; Kassack MU; Lehmann J
    J Med Chem; 2006 Jan; 49(2):760-9. PubMed ID: 16420061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.